MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$408M
Inventory
$153M
Accounts receivable, net
$184M
Investments
$3,204M
Cash and cash
equivalents
$2,595M
Other non-current
assets
$605M
Right-of-use assets,
operating leases
$719M
Property, plant and
equipment, net
$2,134M
Investments, non-current
$2,336M
Total current assets
$6,544M
Total assets
$12,338M
Total liabilities and
stockholders equity
$12,338M
Total stockholders
equity
$8,650M
Total liabilities
$3,688M
Retained earnings
$7,223M
Accumulated other
comprehensive income (loss)
$45M
Additional paid-in capital
$1,382M
Other non-current
liabilities
$285M
Long-term debt
$590M
Financing lease
liabilities, non-current
$20M
Operating lease
liabilities, non-current
$653M
Deferred revenue,
non-current
$153M
Total current
liabilities
$1,987M
Other current
liabilities
$185M
Deferred revenue
$99M
Accrued liabilities
$1,386M
Accounts payable
$317M
Back
Back
Balance Sheet
source: myfinsight.com
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)